Quest Diagnostics Inc (DGX):企業の財務・戦略的SWOT分析

◆英語タイトル:Quest Diagnostics Inc (DGX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME40157FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Quest Diagnostics Inc (DGX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology and diagnostic products. The company caters to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc Key Recent Developments

Apr 13,2021: Quest Diagnostics and Blueprint Genetics to present new insights from genetic testing at the 2021 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
Apr 07,2021: Quest Diagnostics To Release First Quarter 2021 Financial Results On April 22
Mar 17,2021: Study reveals many workers struggling with mental health conditions
Mar 11,2021: Quest Diagnostics updates strategic growth drivers and provides long-term outlook at 2021 Virtual Investor Day
Mar 08,2021: Quest Diagnostics and Mercy broaden access to innovative, convenient lab services in the Midwest

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Quest Diagnostics Inc – Key Facts
Quest Diagnostics Inc – Key Employees
Quest Diagnostics Inc – Key Employee Biographies
Quest Diagnostics Inc – Major Products and Services
Quest Diagnostics Inc – History
Quest Diagnostics Inc – Company Statement
Quest Diagnostics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Quest Diagnostics Inc – Business Description
Product Category: All other
Performance
Product Category: Anatomic pathology testing services
Performance
Product Category: COVID-19 Testing Services
Performance
Product Category: Gene-based and esoteric (including advanced diagnostics) testing services
Performance
Product Category: Routine clinical testing services
Performance
Product Category: DIS Business
Overview
Performance
Key Stats
Product Category: DS Business
Overview
Performance
Quest Diagnostics Inc – Corporate Strategy
Quest Diagnostics Inc – SWOT Analysis
SWOT Analysis – Overview
Quest Diagnostics Inc – Strengths
Quest Diagnostics Inc – Weaknesses
Quest Diagnostics Inc – Opportunities
Quest Diagnostics Inc – Threats
Quest Diagnostics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Quest Diagnostics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Quest Diagnostics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 13, 2021: Quest Diagnostics and Blueprint Genetics to present new insights from genetic testing at the 2021 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting
Apr 07, 2021: Quest Diagnostics To Release First Quarter 2021 Financial Results On April 22
Mar 17, 2021: Study reveals many workers struggling with mental health conditions
Mar 11, 2021: Quest Diagnostics updates strategic growth drivers and provides long-term outlook at 2021 Virtual Investor Day
Mar 02, 2021: 98point6 to provide text-based virtual care for Quest Diagnostics employer health screenings
Feb 24, 2021: Quest Diagnostics introduces new COVID-19 semi-quantitative serology test service
Feb 23, 2021: Quest Diagnostics announces board leadership changes
Feb 16, 2021: EmblemHealth and Quest Diagnostics renew long-standing strategic relationship
Feb 16, 2021: Quest Diagnostics To Speak At Citi”s 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference
Feb 04, 2021: Quest Diagnostics reports fourth quarter and full year 2020 financial results; establishes outlook for first half of 2021
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Quest Diagnostics Inc, Key Facts
Quest Diagnostics Inc, Key Employees
Quest Diagnostics Inc, Key Employee Biographies
Quest Diagnostics Inc, Major Products and Services
Quest Diagnostics Inc, History
Quest Diagnostics Inc, Subsidiaries
Quest Diagnostics Inc, Joint Venture
Quest Diagnostics Inc, Key Competitors
Quest Diagnostics Inc, Ratios based on current share price
Quest Diagnostics Inc, Annual Ratios
Quest Diagnostics Inc, Annual Ratios (Cont...1)
Quest Diagnostics Inc, Annual Ratios (Cont...2)
Quest Diagnostics Inc, Interim Ratios
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Quest Diagnostics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Quest Diagnostics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Quest Diagnostics Inc (DGX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IsoRay Inc (ISR):医療機器:M&Aディール及び事業提携情報
    Summary IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a r …
  • SPAR International:企業の戦略・SWOT・財務分析
    SPAR International - Strategy, SWOT and Corporate Finance Report Summary SPAR International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bank Dhofar SAOG:企業の戦略・SWOT・財務分析
    Bank Dhofar SAOG - Strategy, SWOT and Corporate Finance Report Summary Bank Dhofar SAOG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vaxart Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vaxart Inc (Vaxart) focuses on the development of recombinant vaccines based on its proprietary oral vaccine delivery platform. The company is currently developing tablet vaccines for seasonal and pandemic influenza, norovirus, and Respiratory Syncytial Virus (RSV). Vaxart’s vaccine delivery …
  • PhoreMost Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PhoreMost Ltd (PhoreMost) is a drug discovery company that develops drugs for the treatment of cancer. The company's lead drug discovery program is based on a novel target, which tackles the undruggable cancer gene KRAS that affects various types of cancer. It develops Site-Seeker, a platfor …
  • Teachers Insurance and Annuity Association of America (TIAA):企業のM&A・事業提携・投資動向
    Teachers Insurance and Annuity Association of America (TIAA) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teachers Insurance and Annuity Association of America (TIAA) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report …
  • Guararapes Confeccoes SA:企業の戦略・SWOT・財務情報
    Guararapes Confeccoes SA - Strategy, SWOT and Corporate Finance Report Summary Guararapes Confeccoes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Egdon Resources Plc (EDR):石油・ガス:M&Aディール及び事業提携情報
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Serina Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company’s pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxa …
  • NextEra Energy Resources LLC:電力:M&Aディール及び事業提携情報
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …
  • BESIX Group SA:企業の戦略的SWOT分析
    BESIX Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • China Agri-Industries Holdings Ltd (606):企業の財務・戦略的SWOT分析
    China Agri-Industries Holdings Ltd (606) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Pudumjee Paper Products Limited:企業の戦略・SWOT・財務分析
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Dan Hotels Corporation Ltd:戦略・SWOT・企業財務分析
    Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • American Family Insurance Group:企業の戦略・SWOT・財務情報
    American Family Insurance Group - Strategy, SWOT and Corporate Finance Report Summary American Family Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Boiron SA:企業の戦略・SWOT・財務分析
    Boiron SA - Strategy, SWOT and Corporate Finance Report Summary Boiron SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Fluor Corp (FLR):電力:M&Aディール及び事業提携情報
    Summary Fluor Corp (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other services t …
  • Halozyme Therapeutics Inc (HALO):製薬・医療:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Academia Sinica-製薬・医療分野:企業M&A・提携分析
    Summary Academia Sinica is an academic institution that promotes and undertakes research activities in the disciplines of mathematics and physical sciences, life sciences, and humanities and social sciences. The institution integrates research activities to improve the planning, implementation, and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆